NAMED PATIENT PROGRAM USE OF PEDMARK® TO REDUCE THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH VARIED SOLID TUMORS

Tanaka, RyumaSullivan, MichaelCanpolat, CengizJohnston, RobertAtaseven, EdaAtes, Dilvin CelikDuncan, Catriona2024-08-042024-08-0420231545-50091545-5017https://hdl.handle.net/11616/103736[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]NAMED PATIENT PROGRAM USE OF PEDMARK® TO REDUCE THE RISK OF CISPLATIN-INDUCED OTOTOXICITY IN PEDIATRIC PATIENTS WITH VARIED SOLID TUMORSConference Object70S432S432WOS:001183650902072Q1